Randall Moreadith
Fortune : - $ au 31/08/2026
Fortune : - $ au 31/08/2026
Randall W.
Moreadith was the founder of Oxurion NV, founded in 1996, where the titles held included President & Chief Operating Officer from 1996 to 2003.
Current jobs include President, Chief Executive Officer & Director at Serina Therapeutics (AL), Inc. since 2010; President, Chief Executive Officer & Director at Canaria Therapeutics, Inc.; and Chief Development Officer at Serina Therapeutics, Inc. since 2024.
Former jobs include Chief Medical Officer at Renovis, Inc. from 2004 to 2005; Principal Medical Officer at Quintiles, Inc. (California) from 1996 to 1997; Chief Medical Officer at Tissue Repair Co. from 2006 to 2007; Chief Medical Officer at Post-Hypothermia Corp.; Chief Medical Officer & Executive Vice President at Gene Biotherapeutics, Inc. from 2006 to 2008; and Chief Development Officer & SVP-Drug Development at Nektar Therapeutics in 2009.
Education includes doctorate degrees from Duke University and The Johns Hopkins University, and an undergraduate degree from North Carolina State University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 21/05/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Serina Therapeutics (AL), Inc.
Serina Therapeutics (AL), Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops therapies to treat neurological diseases and pain | Directeur Général | 01/09/2010 |
Canaria Therapeutics, Inc.
Canaria Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Researches, develops and manufactures medical cannabis & cannabinoid treatments | Directeur Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 01/12/2009 |
Taxus Cardium Pharmaceuticals Group, Inc.
Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Directeur Technique/Scientifique/R&D | 01/01/2008 |
Tissue Repair Co.
Tissue Repair Co. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops wound healing products for chronic wounds and aftercare | Directeur Technique/Scientifique/R&D | 02/01/2007 |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur Technique/Scientifique/R&D | 16/12/2005 |
| OXURION NV | Fondateur | 01/01/2003 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 12 |
|---|---|
Nektar Therapeutics
Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Health Services |
Tissue Repair Co.
Tissue Repair Co. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops wound healing products for chronic wounds and aftercare | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Carolina State University
North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Post-Hypothermia Corp.
Post-Hypothermia Corp. Medical SpecialtiesHealth Technology Manufactures and markets temperature modulation therapy devices | Health Technology |
Taxus Cardium Pharmaceuticals Group, Inc.
Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Health Technology |
Oxurion NV
Oxurion NV Pharmaceuticals: MajorHealth Technology Develops innovative vascular biopharmaceuticals for the treatment of eye disease, vascular disease and cancer | Health Technology |
Serina Therapeutics (AL), Inc.
Serina Therapeutics (AL), Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops therapies to treat neurological diseases and pain | Commercial Services |
Canaria Therapeutics, Inc.
Canaria Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Researches, develops and manufactures medical cannabis & cannabinoid treatments | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national